Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Glioblastoma

  • You have access
    Expression of ENO1 Is Up-regulated in Low-grade Glioma and Positively Correlated With Meningioma Grade
    DANG THUY DIEM DINH, SASKIA KUHL, LUKAS GÖRTZ, ROLAND GOLDBRUNNER and MARCO TIMMER
    Anticancer Research May 2022, 42 (5) 2319-2326; DOI: https://doi.org/10.21873/anticanres.15711
  • You have access
    Early Metabolic Changes in 1H-MRSI Predictive for Survival in Patients With Newly Diagnosed High-grade Glioma
    MICHAEL H. WANG, WILSON ROA, KEITH WACHOWICZ, ATIYAH YAHYA, ALBERT MURTHA, JOHN AMANIE, JONATHAN CHAINEY, HARVEY QUON, SUNITA GHOSH and SAMIR PATEL
    Anticancer Research May 2022, 42 (5) 2665-2673; DOI: https://doi.org/10.21873/anticanres.15744
  • You have access
    Association of MGMT Gene Promoter Methylation With Clinicopathological Parameters in Patients With Wild-type IDH Glioblastoma
    MOONSIK KIM, JIHWAN YOO, JONG HEE CHANG and SE HOON KIM
    Anticancer Research January 2022, 42 (1) 335-341; DOI: https://doi.org/10.21873/anticanres.15490
  • You have access
    Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug – Comparison With the Chemotherapeutic Standard-of-care Temozolomide
    AKIRA SUMIYOSHI, SAYAKA SHIBATA, ZHIVKO ZHELEV, THOMAS MILLER, DESSISLAVA LAZAROVA, GENOVEVA ZLATEVA, ICHIO AOKI and RUMIANA BAKALOVA
    Anticancer Research December 2021, 41 (12) 6067-6076; DOI: https://doi.org/10.21873/anticanres.15426
  • You have access
    Large Animal Models of Glioma: Current Status and Future Prospects
    WILLIAM H. HICKS, CYLAINA E. BIRD, MARK N. PERNIK, ALI S. HAIDER, AKSHARKUMAR DOBARIYA, KALIL G. ABDULLAH, SALAH G. AOUN, R. TIMOTHY BENTLEY, AARON A. COHEN-GADOL, ROBERT M. BACHOO, BRUCE E. MICKEY, JUAN M. PASCUAL and TAREK Y. EL AHMADIEH
    Anticancer Research November 2021, 41 (11) 5343-5353; DOI: https://doi.org/10.21873/anticanres.15347
  • You have access
    Cranberry Extract Is a Potent Radiosensitizer for Glioblastoma
    QIAN BAI, ZACHARY E. HUNZEKER, ZIWEN ZHU, MARCO LEQUIO, CONNER M. WILLSON, HUAPING XIAO, MARK R. WAKEFIELD and YUJIANG FANG
    Anticancer Research July 2021, 41 (7) 3337-3341; DOI: https://doi.org/10.21873/anticanres.15121
  • You have access
    Development of Antigen-specific Chimeric Antigen Receptor KHYG-1 Cells for Glioblastoma
    CHUNG HYO KANG, YEONGRIN KIM, SO MYOUNG LEE, SANG UN CHOI and CHI HOON PARK
    Anticancer Research April 2021, 41 (4) 1811-1819; DOI: https://doi.org/10.21873/anticanres.14947
  • You have access
    Newly Synthesized DNA Methyltransferase Inhibitors as Radiosensitizers for Human Lung Cancer and Glioblastoma Cells
    CHAN WOO WEE, JIN HO KIM, HAK JAE KIM, HYUN-CHEOL KANG, SOO YOUN SUH, BEOM SOO SHIN, EUNSOOK MA and IL HAN KIM
    Anticancer Research February 2021, 41 (2) 757-764; DOI: https://doi.org/10.21873/anticanres.14827
  • You have access
    Epidermal Growth Factor Receptor and its Oncogenic EGFRvIII Variant in Benign and Malignant Brain Tumors
    MICHAL KIELBUS, RADOSLAW ROLA, BOZENA JAROSZ, WITOLD JELENIEWICZ, MAREK CYBULSKI, AGNIESZKA STENZEL-BEMBENEK, ARKADIUSZ PODKOWINSKI, JOLANTA SMOK-KALWAT, KRZYSZTOF POLBERG, TOMASZ TROJANOWSKI, DAWID STEFANIUK and ANDRZEJ STEPULAK
    Anticancer Research February 2021, 41 (2) 983-991; DOI: https://doi.org/10.21873/anticanres.14852
  • You have access
    Anti-cancer Effects of Fucoxanthin on Human Glioblastoma Cell Line
    FLAVIA GARCIA LOPES, KAREN ANDRINEIA OLIVEIRA, RAFAEL GARCIA LOPES, GABRIELA GODOY POLUCENO, CARMEN SIMIONI, DA SILVA PESCADOR GABRIEL, CLAUDIA MARLENE BAUER, MARCELO MARASCHIN, ROBERTO BIANCHINI DERNER, RICARDO CASTILHO GARCEZ, CARLA INES TASCA and CLAUDIA BEATRIZ NEDEL
    Anticancer Research December 2020, 40 (12) 6799-6815; DOI: https://doi.org/10.21873/anticanres.14703

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire